News

The confidential agreement reached by the NHS and the manufacturer is expected to assist up to 1,600 women annually who have high-risk, triple-negative breast cancer. When combined with chemotherapy, pembrolizumab (trade name Keytruda®) reduces the likelihood of breast cancer...

The 64th annual meeting of the American Society of Hematology, a prestigious venue for some of their field's most significant research, will be held in New Orleans in December, and blood disease specialists and medical professionals will fly there. With...

In the first clinical trial of its sort, lab-grown blood cells were administered to a second patient, potentially paving the way for future therapies for blood disorders like sickle cell. At the NHS Blood and Transplant (NHSBT) Advanced Therapies Unit...

As a part of the proposed free trade deal with Britain, India is looking at expanding access to markets for its pharmaceutical products in the UK, an official said on November 4. The official added that a leaked chapter...

The effectiveness of aducanumab and donanemab in treating Alzheimer's disease (AD) was successfully simulated using a novel computer model, demonstrating how a steady rise in dosage until reaching the maximum dose helps to minimize cognitive loss and limit adverse...

Pharma confidence in growth, innovation, and process efficiency has reached record highs, according to the results of the CPhI's 2022 Pharma Index poll, which were released at this year's CPhI Frankfurt. This bodes well for the industry's prospects in...

Good laboratory practices are important because they keep labs from misinterpreting their results and prevent contamination. As such, GLPs are especially important when dealing with living organisms or cells, which can spread disease and cause other forms of infection...